Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for AUD Comorbid With PTSD
NCT03248167Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), sponsored by NYU Langone Health. Started Sep 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03248167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248167.